NCT02286752View on ClinicalTrials.gov

Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.

PHASE4CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Incidence of Postoperative Nausea and Vomiting
Interventions
DRUG

Neostigmine

for reversal of neuromuscular block: 0,05 mg kg-1 neostigmine + 0,025 mg kg-1 atropine

DRUG

sugammadex

for reversal of neuromuscular block: sugammadex 2 mg kg-1

Trial Locations (1)

52100

Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital, Altinordu

All Listed Sponsors
lead

T.C. ORDU ÜNİVERSİTESİ

OTHER

NCT02286752 - Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting. | Biotech Hunter | Biotech Hunter